Jennifer Doan

Array ( [id] => 247106 [patent_doc_number] => 07585858 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-08 [patent_title] => 'N-sulfonylcarboximidamide apoptosis promoters' [patent_app_type] => utility [patent_app_number] => 11/138717 [patent_app_country] => US [patent_app_date] => 2005-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19216 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/585/07585858.pdf [firstpage_image] =>[orig_patent_app_number] => 11138717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6978586 [patent_doc_number] => 20050288304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Tetrahydronaphthylpiperazines as 5HT1B antagonists, inverse agonists and partial agonists' [patent_app_type] => utility [patent_app_number] => 11/135215 [patent_app_country] => US [patent_app_date] => 2005-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20550 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288304.pdf [firstpage_image] =>[orig_patent_app_number] => 11135215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7740641 [patent_doc_number] => 08106044 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => '8-{4-[3-(5-fluoro-1H-indol-3-yl)-propyl]-piperazin-1-yl}-2-methyl-4H-benzo[1,4]oxazin-3-one mesylate with high affinity for the dopamine D2 receptor and the serotonin reuptake site' [patent_app_type] => utility [patent_app_number] => 11/134455 [patent_app_country] => US [patent_app_date] => 2005-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 815 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/106/08106044.pdf [firstpage_image] =>[orig_patent_app_number] => 11134455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5743641 [patent_doc_number] => 20060089366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'New piperazine and piperidine compounds' [patent_app_type] => utility [patent_app_number] => 11/129465 [patent_app_country] => US [patent_app_date] => 2005-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2825 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20060089366.pdf [firstpage_image] =>[orig_patent_app_number] => 11129465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753248 [patent_doc_number] => 20080161323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Piperazine Derivatives of Alkyl Oxindoles' [patent_app_type] => utility [patent_app_number] => 11/596465 [patent_app_country] => US [patent_app_date] => 2005-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6992 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161323.pdf [firstpage_image] =>[orig_patent_app_number] => 11596465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7691414 [patent_doc_number] => 20070232619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Piperazine Derivatives of Dialkyl Oxindoles' [patent_app_type] => utility [patent_app_number] => 11/596473 [patent_app_country] => US [patent_app_date] => 2005-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 42993 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232619.pdf [firstpage_image] =>[orig_patent_app_number] => 11596473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5063655 [patent_doc_number] => 20070225295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Ziprasidone Hydrochloride Polymorph and Process for Its Preparation' [patent_app_type] => utility [patent_app_number] => 11/568913 [patent_app_country] => US [patent_app_date] => 2005-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 1594 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20070225295.pdf [firstpage_image] =>[orig_patent_app_number] => 11568913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4977976 [patent_doc_number] => 20070219209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Piperazine Derivatives Of Alkyl Oxindoles' [patent_app_type] => utility [patent_app_number] => 11/596466 [patent_app_country] => US [patent_app_date] => 2005-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10659 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20070219209.pdf [firstpage_image] =>[orig_patent_app_number] => 11596466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250701 [patent_doc_number] => 20050272745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Novel piperidine and piperazine derivatives' [patent_app_type] => utility [patent_app_number] => 11/125335 [patent_app_country] => US [patent_app_date] => 2005-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35958 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272745.pdf [firstpage_image] =>[orig_patent_app_number] => 11125335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 676053 [patent_doc_number] => 07087610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-08 [patent_title] => 'Benzothiazole antiviral agents' [patent_app_type] => utility [patent_app_number] => 11/125066 [patent_app_country] => US [patent_app_date] => 2005-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5405 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/087/07087610.pdf [firstpage_image] =>[orig_patent_app_number] => 11125066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 497480 [patent_doc_number] => 07208492 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-24 [patent_title] => 'Topoisomerase-targeting agents' [patent_app_type] => utility [patent_app_number] => 11/121292 [patent_app_country] => US [patent_app_date] => 2005-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11717 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/208/07208492.pdf [firstpage_image] =>[orig_patent_app_number] => 11121292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6945296 [patent_doc_number] => 20050197345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Pyrrolidine sulfonamides' [patent_app_type] => utility [patent_app_number] => 11/119026 [patent_app_country] => US [patent_app_date] => 2005-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5036 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20050197345.pdf [firstpage_image] =>[orig_patent_app_number] => 11119026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769296 [patent_doc_number] => 20060019964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 11/112048 [patent_app_country] => US [patent_app_date] => 2005-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8741 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019964.pdf [firstpage_image] =>[orig_patent_app_number] => 11112048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1077042 [patent_doc_number] => 07615555 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-10 [patent_title] => 'Piperidine derivatives as modulators of chemokine receptor CCR5' [patent_app_type] => utility [patent_app_number] => 11/587330 [patent_app_country] => US [patent_app_date] => 2005-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35548 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/615/07615555.pdf [firstpage_image] =>[orig_patent_app_number] => 11587330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7046168 [patent_doc_number] => 20050250763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 11/107052 [patent_app_country] => US [patent_app_date] => 2005-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7127 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250763.pdf [firstpage_image] =>[orig_patent_app_number] => 11107052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6912974 [patent_doc_number] => 20050176732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Enantiomers of 1-(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine' [patent_app_type] => utility [patent_app_number] => 11/106613 [patent_app_country] => US [patent_app_date] => 2005-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10937 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176732.pdf [firstpage_image] =>[orig_patent_app_number] => 11106613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7138390 [patent_doc_number] => 20050182069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine' [patent_app_type] => utility [patent_app_number] => 11/106528 [patent_app_country] => US [patent_app_date] => 2005-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10928 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20050182069.pdf [firstpage_image] =>[orig_patent_app_number] => 11106528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7138391 [patent_doc_number] => 20050182070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Method for the treatment of allergic conditions' [patent_app_type] => utility [patent_app_number] => 11/106456 [patent_app_country] => US [patent_app_date] => 2005-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11010 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20050182070.pdf [firstpage_image] =>[orig_patent_app_number] => 11106456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7138369 [patent_doc_number] => 20050182068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues' [patent_app_type] => utility [patent_app_number] => 11/103246 [patent_app_country] => US [patent_app_date] => 2005-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38831 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20050182068.pdf [firstpage_image] =>[orig_patent_app_number] => 11103246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5259714 [patent_doc_number] => 20070213346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Substituted 4-Alkyl-And 4-Alkanoyl-Piperidine Derivatives And Their Use As Neurokinin Antagonists' [patent_app_type] => utility [patent_app_number] => 11/547868 [patent_app_country] => US [patent_app_date] => 2005-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18830 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213346.pdf [firstpage_image] =>[orig_patent_app_number] => 11547868 [rel_patent_id] =>[rel_patent_doc_number] =>)